1,738 results on '"Drummond, Michael"'
Search Results
2. Digital Pedagogies for Sustainable Futures: The Role of Gamification to Enhance Student Learning
3. Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses”
4. Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement
5. The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review
6. Single-cell analysis of human basal cell carcinoma reveals novel regulators of tumor growth and the tumor microenvironment
7. Colonoscopy vs the Fecal Immunochemical Test: Which is Best?
8. Commentary: Advocating for patient and public involvement and engagement in health economic evaluation
9. How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?
10. Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income Countries
11. Transparency, openness, and reproducible research practices are frequently underused in health economic evaluations
12. Disparities in access to food and chronic obstructive pulmonary disease (COPD)-related outcomes: a cross-sectional analysis
13. Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease Treatments
14. Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration
15. GRADE guidance 23: considering cost-effectiveness evidence in moving from evidence to health-related recommendations
16. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
17. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures
18. Single cell transcriptomics of human epidermis identifies basal stem cell transition states.
19. Laboratory culture of the California Sea Firefly Vargula tsujii (Ostracoda: Cypridinidae): Developing a model system for the evolution of marine bioluminescence
20. Ancient secretory pathways contributed to the evolutionary origin of an ecologically impactful bioluminescence system
21. Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability
22. Consideration of quality of life in the health technology assessments of rare disease treatments
23. Single cell transcriptomics of human epidermis reveals basal stem cell transition states
24. Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report
25. European union regulation of health technology assessment: what is required for it to succeed?
26. Promoting innovation while controlling cost: The UK's approach to health technology assessment
27. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
28. Should health technology assessment be more patient centric? If so, how?
29. Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges
30. Actin polymerization controls cilia-mediated signaling
31. Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe
32. Real-world evidence for coverage determination of treatments for rare diseases
33. Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective
34. Modeling the Structures of Ternary Complexes Mediated by Molecular Glues
35. Cloud‐Native Rendering Platform and GPUs Aid Drug Discovery
36. Economic evaluation of nutrition interventions: Does one size fit all?
37. A Value Framework for the Assessment of Diagnostic Technologies: A Proposal Based on a Targeted Systematic Review and a Multistakeholder Deliberative Process in Latin America
38. Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
39. Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis
40. Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort
41. Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses”
42. Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline
43. Challenges of calculating cost-effectiveness thresholds – Authors' reply
44. Is rate of return pricing a useful approach when value-based pricing is not appropriate?
45. An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
46. Brief Report: HIV Is Associated With Impaired Pulmonary Diffusing Capacity Independent of Emphysema
47. ‘Mapping’ Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases
48. Patient Preferences in the Medical Product Lifecycle
49. Myth #5: Health Care Is Rightly Left to the Private Sector, for the Sake of Efficiency
50. Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.